The Genome Stability and Innate Immunity Team, led by Dr Christian Zierhut, seeks to understand how innate immune responses are activated during genotoxic stress, and to establish how these regulate cell fate. Ultimately, we aim to develop rule sets for how cell fate can be manipulated during cancer therapy. We employ a multi-disciplinary approach that combines state of the art cell biology, genetic screening, biochemistry and structural biology techniques.